EI
INBX icon

Ethic Inc’s Inhibrx INBX Stock Holding History

Ethic Inc’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$638K Sell
9,488
-3,483
-27% -$258K 0.01% 785
2025
Q4 		$1.02M Sell
12,971
-1,516
-10% -$103K 0.02% 639
2025
Q3 		$488K Sell
14,487
-1,252
-8% -$30.8K 0.01% 844
2025
Q2 		$227K Buy
+15,739
New +$203K ﹤0.01% 1071

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ethic Inc's INBX Position: Q1 2026 in Review

Ethic Inc reduced its Inhibrx (INBX) stake by 27% in Q1 2026, selling an estimated $258K and leaving 9,488 shares worth $638K. The position accounts for 0.01% of the portfolio, ranked #785.

Ethic Inc first reported a position in INBX in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.02M in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Ethic Inc held 9,488 shares of Inhibrx worth $638K as of Q1 2026.
  • Ethic Inc sold 3,483 Inhibrx shares in Q1 2026, an estimated $258K.
  • Inhibrx made up 0.01% of Ethic Inc's portfolio in Q1 2026, its #785 holding.
  • Ethic Inc first reported a position in Inhibrx in Q2 2025 and has held it in 4 quarters since.
  • Ethic Inc's Inhibrx position peaked at $1.02M in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Ethic Inc's 13F filing for Q1 2026, filed 27 Apr 2026.